Study Commissioned To Learn The Problems Faced By Pharmaceutical Companies

by Dr. Sunil Shroff on  March 13, 2008 at 5:25 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Study Commissioned To Learn The Problems Faced By Pharmaceutical Companies
The Department of Scientific and Industrial Research (DSIR) in the Ministry of Science and Technology commissioned a study to "Institute for Studies in Industrial Development" on the subject - "Defining the Role of Government in Trans-nationalization Efforts of Indian SMEs: A Case Study of Indian Pharmaceutical Industry".

The Institute, in the final report submitted to DSIR, has highlighted certain weaknesses of pharmaceutical small and medium enterprises (SMEs) in their endeavour towards trans-nationalization and exports.

These include: lack of expertise, training and finance for technological up-gradation and adoption of good manufacturing practices (GMP) by SMEs to meet global quality standards; limited exposure and expertise on IPR issues; limited adoption of information technology (IT) techniques in production and processes; low or negligible R&D expenditure which affects the ability of SMEs to offer innovative solutions; and the inability of SMEs to access finance on easy terms for import of capital goods and undertaking advertising and marketing activities.

The steps taken or proposed to be taken by the Central Government to enable the small and medium pharmaceutical companies to face the stiff challenges posed by big pharmaceutical companies include: availability of financial assistance up to Rs.1 crore with 15% capital subsidy to small scale drug and pharma units for technology up-gradation under the credit linked capital subsidy scheme of Ministry of Micro, Small and Medium Enterprises (MSME); proposal of Department of Chemicals and Petrochemicals to extend 5% interest subsidy to pharma small scale units for technology up-gradation on the basis of Schedule 'M' of Drugs and Cosmetic Rules, 1945; support to high-risk pre-proof-of-concept research and late stage development in small and medium companies in the areas of agriculture, human and animal health, environment, diagnostics, immuno-biologicals and various industrial products like antibiotics, industrial enzymes, vitamins etc. under the Small Business Innovation Research Initiative (SBIRI) scheme launched by the Department of Bio-technology.

Ministry of MSME has also taken a step to enable small and medium companies, in general to face challenges of stiff competition by formulating a National Manufacturing Competitiveness Programme (NMCP), worked out by the National Manufacturing Competitiveness Council (NMCC) in consultation with industry.

Under this programme, a "major promotional package" has been announced to provide full support to the SMEs in the areas of credit, technological up-gradation, marketing and up-gradation of industrial infrastructure.

This information was given by Union Minister for Science & Technology and Earth Sciences, Shri Kapil Sibal, in the Lok Sabha today.

Source: PIB

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Yes, government subsidy & tax benefits are the one aspect but government has to give quality certificate to the product of SMEs, so that customer trusts it’s product against the big counterparts. Uses of IT help to highlight quality & price which result in volume reach of SME’s product.SBU also help to give better quality at competitive price


my mum need Gefitinib from Natco Pharma Ltd, I cann't find survey result from India Goverment Authority.

More News on:

Drug Toxicity 

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive